Related Experiment Video
Updated: Jul 14, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among
P M Ridker1, J Danesh, L Youngman
1Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA. pridker@partners.org
Annals of Internal Medicine
|August 7, 2001
Summary
Helicobacter pylori exposure showed no significant association with an increased risk of myocardial infarction in initially healthy U.S. men. This study found limited evidence linking H. pylori seropositivity to future heart attack risk.
Area of Science:
- Cardiovascular Disease Research
- Infectious Disease Epidemiology
- Gastroenterology
Background:
- The link between Helicobacter pylori infection and cardiovascular disease remains debated.
- Investigating H. pylori's role in heart conditions is crucial for public health.
Purpose of the Study:
- To investigate the association between prior Helicobacter pylori exposure and myocardial infarction risk.
- To determine if H. pylori seropositivity correlates with increased cardiovascular events.
Main Methods:
- A prospective case-control study design was employed.
- Utilized data from the Physicians' Health Study, including initially healthy U.S. men.
- Measured IgG antibody titers against H. pylori and inflammatory markers in baseline blood samples from myocardial infarction patients and controls.
Main Results:
- Baseline H. pylori seropositivity rates were comparable between case-patients (43.4%) and controls (44.3%).
- No significant association was observed between H. pylori exposure and the risk of myocardial infarction (rate ratio, 0.96).
- Limited evidence suggested no link between seropositivity magnitude and risk, or between seropositivity and inflammatory biomarkers.
Conclusions:
- In a socioeconomically uniform population, H. pylori exposure demonstrated limited association with future myocardial infarction risk.
- Findings suggest H. pylori may not be a significant determinant of cardiovascular events in this cohort.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...